Zai Lab Limited (NASDAQ: ZLAB) is one of the 12 Stocks That Will Rebound According to Wall Street Analysts. On January 6, UBS initiated coverage on Zai Lab Limited (NASDAQ: ZLAB), giving the stock a Buy rating and setting the price target at $35.
The research firm noted that the company was moving beyond its previous focus on China to become a global innovation leader. UBS considers Zai Lab Limited (NASDAQ: ZLAB) to be undervalued and highlights that the market does not fully recognize the value of its global portfolio, which enhances its strategic positioning, diversifies its revenue streams and creates potential long-term shareholder value.
The company also noted that this pipeline is moving toward innovative, high-value treatments aimed at addressing significant unmet needs. According to UBS, this could significantly influence the growth of Zai Lab Limited (NASDAQ: ZLAB) over the next decade.
Separately, on January 6, Zai Lab Limited (NASDAQ: ZLAB) announced that the National Medical Products Administration (NMPA) in China has approved the supplemental new drug application (sNDA) for AUGTYRO (repotrectinib). The drug is approved for adult patients with solid tumors harboring a neurotrophic receptor tyrosine kinase (NTRK) gene fusion.
Zai Lab Limited (NASDAQ: ZLAB) is a commercial biopharmaceutical company based in China and the United States. It focuses on the discovery, development and commercialization of therapies that address pathologies with significant unmet needs in oncology, immunology, neuroscience and infectious diseases.
While we recognize ZLAB’s potential as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for a hugely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the reshoring trend, check out our free report on the best AI stock in the short term.
READ NEXT: 10 Best US Penny Stocks to Buy And 10 Best New Penny Stocks to Invest in.
Disclosure: None. This article was originally published on Initiated Monkey.
